Linde posted record Q2 sales and EPS, backed by an $8.1B backlog and $1B of electronics wins. The stock looks expensive, but its contracted industrial gas model and AI-linked demand keep the Buy case intact.
Linde plc (LIN) is a high-quality industrial gas compounder with strong exposure to semiconductor manufacturing, healthcare, aerospace, data-center construction and decarbonization projects. Q2 2026 revenue reached $9.29B, up 9% year over year, while adjusted EPS rose 10% to $4.50. The record $8.1B sale-of-gas backlog and $1B of new electronics wins give the growth story tangible support.
The central tension is valuation versus execution. LIN trades at 30.0x trailing earnings, 23.7x forward earnings and 1.8x PEG. Those are premium figures for a materials company, but Linde produced 20.3% net margins in 2025, delivered a seven-quarter streak of earnings beats, and guided to $17.70 to $17.90 of adjusted EPS for 2026. The stock is not a bargain at $461.62, yet its infrastructure, contract profile and project backlog support a premium to more cyclical chemical businesses.
The main constraint is capital intensity. Debt rose to $26.99B at the end of 2025 and $28.01B by June 2026, while 2025 capital expenditures reached $5.26B. Q2 operating margin fell to 29.5% from 30.1% a year earlier, pressured by U.S. homecare and lower-margin equipment sales. For a moderate-risk investor with a medium-term horizon, the evidence supports a Buy, with the strongest risk-adjusted entry points below the current quote.
Linde is a global industrial gas and engineering company founded in 1879 and based in Woking, the United Kingdom. Its shares trade on Nasdaq under LIN. The company employs 64,649 people and operates across the United States, Canada, Mexico, Brazil, Germany, the United Kingdom, China, South Korea, India, Australia and other markets in more than 80 countries.
The product portfolio includes atmospheric gases such as oxygen, nitrogen, argon and rare gases, along with process gases including hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases and acetylene. Linde also designs and constructs air separation, hydrogen, synthesis, olefin and natural gas plants.
Linde serves chemicals and energy, food and beverage, electronics, healthcare, manufacturing, metals and mining. This spread gives LIN exposure to both defensive demand and industrial cycles. Medical oxygen and food packaging support recurring consumption, while semiconductor fabs, aerospace and clean-energy projects provide higher-growth investment channels.
Linde's 2025 revenue mix was led by the Americas at $15.21B, or 45.9% of total revenue. EMEA contributed $8.55B, or 25.8%, APAC generated $6.66B, or 20.1%, and Engineering produced $2.70B, or 8.2%.
The mix is moving toward electronics and project start-ups. Management said almost half of the Q2 volume increase came from project start-ups in APAC and the Americas. That is important because contracted plant investments can convert today's capital spending into multi-year gas revenue.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Linde's flagship offering is the integrated sale-of-gas platform, combining atmospheric gases, process gases, production plants, storage and logistics. Oxygen, nitrogen and argon serve broad industrial applications, while hydrogen, helium and electronic gases target specialized customers with demanding purity and reliability requirements.
The most attractive current product area is electronic gases. Management reported 18% year-over-year electronics growth in Q2 and cited demand tied to AI hardware. The company added $1B of U.S. electronics wins to its backlog and is investing in plants that will supply advanced-node fabs in the Western United States.
Helium is a second important product case. Linde maintained reliable supply for contracted customers during Strait of Hormuz disruption, signed new long-term contracts and achieved price improvement. Higher dislocation costs limited the near-term margin benefit, but management expects the helium market to normalize in 2027.
Linde's advantage is less about a single patent and more about physical assets, customer integration and operating know-how. Its pipeline networks, onsite plants and long-term supply arrangements are difficult to replace after a customer has built production around them. The 2025 annual report identifies pipeline density as a competitive advantage in large onsite supply situations.
The electronics pipeline demonstrates how this advantage compounds. Linde has an existing plant network in Arizona, won $1B of additional U.S. electronics projects and secured Taiwan joint-venture projects requiring approximately $800M of investment in air separation units and hydrogen production units.
Linde also combines sale-of-gas and sale-of-plant models. Management said customers with very large propellant needs, including certain commercial-space companies, can choose customer-owned plants operated and maintained by Linde. That flexibility lets Linde participate even when a customer prefers vertical integration.
The operating system is capital intensive but built around recurring supply. Linde expects to start more than 20 projects during the remainder of 2026, representing approximately $1.3B of investment. Management expects the sale-of-gas backlog to finish the year with an 8 handle even after those start-ups.
Energy is Linde's single largest production and distribution cost, according to the 2025 annual report. Q2 cost pass-through increased sales by 1%, while broad-based price increases added 2%. This contract structure does not eliminate volatility, but it gives Linde a mechanism to recover a portion of power and feedstock inflation.
The helium response also highlights supply-chain capability. Linde cited diverse sources, maintained supply-chain logistics and tank capacity, and continued serving contracted customers during Middle East disruption. The same network helps explain why customers pay for reliability instead of treating gases as interchangeable commodities.
Industry research places the global industrial gases market at $98.79B in 2025 and $126.53B by 2030, implying a 5.1% revenue CAGR. A separate volume-based estimate projects 4.0% annual growth from 2026 through 2031. These figures frame a steady market, while Linde's 2025 revenue growth of 9.3% and earnings growth of 11.3% show performance above the broad industry rate.
Semiconductors are the clearest growth engine. Linde reported electronics as its fastest-growing end market in Q2, supported by advanced-node fabs and AI-related hardware. Healthcare and food and beverage provide a more defensive base, while aerospace and data-center construction are supporting U.S. manufacturing demand.
Hydrogen, low-carbon ammonia, carbon capture and low-carbon steel expand the addressable market, but they also require significant capital. Linde's combination of engineering and gas-production assets gives it a credible route into those projects, provided project returns remain disciplined.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Linde's customers range from semiconductor fabs and hospitals to steelmakers, chemical producers, food processors, aerospace companies and energy projects. The products are often production-critical. A semiconductor customer needs consistent ultra-high-purity gases, while a hospital needs dependable medical oxygen. Both use cases reward uptime and supply assurance.
Onsite contracts typically run for 10 to 20 years and include minimum purchase requirements and price-escalation provisions. That structure creates revenue visibility and helps align Linde's plant investment with customer demand. The $8.1B sale-of-gas backlog shows the model in action.
Customer economics also explain the hybrid model. Some commercial-space customers want to own atmospheric-gas plants because of their large propellant requirements, while Linde continues to see a stronger sale-of-gas opportunity in hydrogen. Linde can serve both approaches through engineering, operation and maintenance capabilities.
Linde competes globally with Air Liquide and Air Products, as well as Messer Group, Taiyo Nippon Sanso and regional suppliers. Linde and Air Liquide occupy the top tier of the global industrial gas market, while Air Products remains a major competitor in hydrogen and large-scale project development.
Air Liquide's electronics business includes carrier-gas contracts with an average duration of 15 years, demonstrating that long-duration customer relationships are an industry feature rather than a Linde-only advantage. Linde's own 10 to 20-year onsite contracts and pipeline network therefore need to be defended through execution, density and capital discipline.
Air Products has emphasized a refocus on core industrial gases and capital allocation discipline. That shift gives Linde an opportunity to win projects, but it also confirms that large competitors are pursuing the same electronics, hydrogen and energy-transition opportunities. Linde's $8.1B backlog and 23.5% Q2 return on capital provide strong evidence of current execution.
Linde's exposure is balanced but not immune to the industrial cycle. Healthcare and food and beverage remained consistent in management's Q2 outlook, while chemicals and energy grew at low-single-digit rates and remained more volatile. Manufacturing improved across the Americas and APAC, with U.S. aerospace accounting for more than one-third of manufacturing growth.
The Strait of Hormuz disruption affected helium logistics and reduced industrial activity in hydrocarbon-dependent parts of Asia, including India, some ASEAN markets and Australia. Management left 2026 guidance intact, but said helium normalization would progress into early 2027 rather than fully normalize during 2026.
Trade conflicts, tariffs, energy prices, raw-material availability and environmental regulation are identified risks in Linde's annual-report disclosures. The Q2 guidance assumption of no economic improvement at the midpoint gives the outlook a conservative base, while the $17.70 to $17.90 full-year EPS range leaves room for operating execution to matter more than a broad macro rebound.
Debt climbed to $28.01B by June 2026 while capital expenditures hit $5.26B in 2025, underscoring the company’s capital-heavy growth model.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Q2 revenue rose 9% to $9.29B and adjusted EPS increased 10% to $4.50, with net margins still running at 20.3% in 2025.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Management guided to $17.70 to $17.90 of adjusted EPS for 2026 after delivering a seven-quarter streak of earnings beats.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →LIN trades at 30.0x trailing earnings, 23.7x forward earnings and 1.8x PEG, a premium that reflects its quality but leaves limited room for disappointment.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The stock was quoted at $461.62 versus a fair value of $520, with the strongest risk-adjusted entry points described as below the current price.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Linde combines the characteristics investors usually want in a long-term industrial holding: recurring contracts, mission-critical products, high margins, global scale and a visible project pipeline. Q2 2026 added evidence through $9.29B of revenue, $4.50 of adjusted EPS and a record $8.1B sale-of-gas backlog.
The investment is not risk-free. Debt has climbed, capital spending is heavy, the U.S. homecare business is weighing on margins and helium logistics remain exposed to geopolitical disruption. Still, management's $17.70 to $17.90 full-year EPS guidance, seven consecutive completed-quarter beats and electronics-led backlog support a positive medium-term view.
At $461.62, LIN is investable but not deeply discounted. The Buy recommendation is strongest for investors who value durable compounding and can tolerate paying a premium for quality. The disciplined approach is to build exposure below the current quote and reserve aggressive buying for the $440 or $390 levels.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
Marc Lichtenfeld's Oxford Income Letter promotes the “SpaceX Royalty” Portfolio. We identify the two companies and test the promised income claim.
Linde plc (LIN) beat Q2 estimates on EPS and revenue, but shares fell as investors zeroed in on margin pressure and a cautious second-half outlook. This deep-dive breaks down what drove the top-line strength, where profitability slipped, and why guidance only partially reassured the market.
Linde plc (LIN) drops 6.2% as investors react to earnings beats, with shares sliding despite stronger-than-expected results.